WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Group A2 Robert Dillion, Cyclosporine contraindicated before giving live vaccines BCG Vaccine, Type IV hypersensitivity pathologic mechanism behind Stevens-Johnson Syndrome (SJS), Type IV hypersensitivity only hypersensitivty that is Cell-mediated, IgG main antibody in serum Type III hypersensitivity, Robert Dillon is a 28-year-old Hispanic male who presents to the clinic with a blistering, painful rash that has worsened over the past 7 days. patient likely is presenting with Type IV hypersensitivity, BCG Vaccine rare chance to cause Anaphylaxis, Cell-mediated MHC II classes are involved in MHC molecules, Robert Dillon is a 28-year-old Hispanic male who presents to the clinic with a blistering, painful rash that has worsened over the past 7 days. pt was recently treated with Sulfonamides, Antivenom is a main cause of Serum Sickness, Anaphylaxis treated with Epinephrine, Antibody-mediated antibody comples deposit in blood vessels leading to Vasculitis, IgE triggers release of inflammatory mediators like histamine and bradykinin upon allergen exposure Bradykinin, T-helper cells Can be tested with PPD (Purified Protein Derivative) PPD, Type II hypersensitivity involved in initial, acute phase responses IgM, Type III hypersensitivity pathogenic mechanism of Serum Sickness, Bradykinin release results in inflammation of blood vessels Vasculitis, Serum Sickness serum sickness mediated by antibodies in blood vessels Antibody-mediated, IgG Can target host cells, leading to cell damage, like in Myasthenia Gravis where antibodies target acetylcholine receptors in the NMJ Myasthenia Gravis, TCR Involved in Type IV hypersensitivity (cell- mediated hypersensitivity) T-helper cells, Muscle Pain treated with MET